Laurus Labs saw no growth in patent filings and highest growth of 1.99% in grants in May in Q2 2024. Compared to Q1 2024, Q2 2024 saw no growth in patent filings and grants by 1.99%. GlobalData’s DataBook provides a comprehensive analysis of Laurus Labs‘s patent filings and grants. Buy the databook here.
Smarter leaders trust GlobalData
Laurus Labs has been focused on protecting inventions in Spain(ES) with two publications in Q2 2024
The Spain(ES) Patent Office dominates the patent grants with nearly 100% of grants. The United States(US), Spain(ES), and European Patent Office(EPO) patent Office are among the top ten patent offices where Laurus Labs is filings its patents. Among the top granted patent authorities, Laurus Labs has 100% of its grants in Spain(ES).
Eli Lilly and Co could be the strongest competitor for Laurus Labs
Patents related to rare diseases lead Laurus Labs's portfolio
Laurus Labs has the highest number of patents in rare diseases. For rare diseases, nearly 100% of patents were filed and no patents were granted in Q2 2024.
Cystic fibrosis related patents lead Laurus Labs portfolio
Laurus Labs has highest number of patents in cystic fibrosis.
For comprehensive analysis of Laurus Labs's filings and grants, buy the databook here.
Data Insights
From
The gold standard of business intelligence.
Blending expert knowledge with cutting-edge technology, GlobalData’s unrivalled proprietary data will enable you to decode what’s happening in your market. You can make better informed decisions and gain a future-proof advantage over your competitors.
GlobalData patents database covers bibliographic from all 100+ patenting authorities. All patents are tagged to 18+ industries and 300+ sub-sectors based on technology classification, keywords, and associated companies. They are also tagged to various industries themes (100+) and technology domains (1800+) of focus.
Patents database further disambiguates assignee names (13m names) and associate corporate tree hierarchy in current/point in time ownerships (320k entities). GlobalData sources content directly from national patent offices on a weekly basis.
